Intellia Therapeutics, Inc vs. QuidelOrtho Corporation Common Stock
NTLA
Intellia Therapeutics, Inc
$12.14 -0.98%
VS QDELQuidelOrtho Corporation Common Stock
$11.78 -3.05%
Intellia Therapeutics, Inc and QuidelOrtho Corporation Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| NTLA | QDEL | |
|---|---|---|
| Market Cap | $1.72 billion | $833.19 million |
| Revenue (TTM) | $59.51 million | $2.67 billion |
| Net Income (TTM) | $-399,975,000 | $-1,048,400,000 |
NTLA leads on 2 of 3 size & scale factors.
Valuation
| NTLA | QDEL | |
|---|---|---|
| Price / Book | 2.36 | 0.47 |
| Price / Sales | 28.87 | 0.31 |
QDEL leads on 2 of 2 valuation factors.
Profitability
| NTLA | QDEL | |
|---|---|---|
| Net Margin | -672.16% | -39.20% |
| Return on Equity | -54.96% | -59.07% |
NTLA and QDEL split the profitability factors evenly.
Risk & Sentiment
| NTLA | QDEL | |
|---|---|---|
| Short Interest | 2.43% | 5.40% |
NTLA leads on 1 of 1 risk & sentiment factors.
Dig deeper: NTLA overview, NTLA financials, QDEL overview, QDEL financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.